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Abstract
Background: Cancer remains a major cause of morbidity and mortality worldwide. In developing countries, data
on lung cancer mortality are scarce.
Methods: Using South Africa’s annual mortality and population estimates data, we calculated lung cancer age-
standardised mortality rates for the period 1995 to 2006. The WHO world standard population was used as the
reference population. Scatter plots and regression models were used to assess linear trends in mortality rates. To
better characterise emerging trends, regression models were also partitioned for defined periods.
Results: Lung cancer caused 52,217 deaths during the study period. There were 4,525 deaths for the most recent
year (2006), with men accounting for 67% of deaths. For the entire South African population, the age-standardised
mortality rate of 24.3 per 100,000 persons in 1995 was similar to the rate of 23.8 per 100,000 persons in 2006.
Overall, there was no significant decline in lung cancer mortality in South Africa from 1995 to 2006 (slope = -0.15,
p = 0.923). In men, there was a statistically non-significant annual decline of 0.21 deaths per 100,000 persons (p =
0.433) for the study period. However, from 2001 to 2006, the annual decline of 1.29 deaths per 100,000 persons
was statistically significant (p = 0.009). In women, the mortality rate increased significantly at an annual rate of 0.19
per 100,000 persons (p = 0.043) for the study period, and at a higher rate of 0.34 per 100,000 persons (p = 0.007)
from 1999 to 2006.
Conclusion: The more recent declining lung cancer mortality rate in men is welcome but the increasing rate in
women is a public health concern that warrants intervention. Smoking intervention policies and programmes need
to be strengthened to further reduce lung cancer mortality in men and to address the increasing rates in women.
Background
Cancer is a major cause of morbidity and mortality,
worldwide. The World Health Organisation (WHO)
estimates show that the global burden of cancer is
increasing, with new cases expected to rise by 50% over
the next 20 years [1]. Research published in 2010 esti-
mated that, globally, there were 12.7 million new cases
of cancer with 7.6 million deaths in 2008; 56% of new
cases and 63% of cancer deaths occurred in developing
countries [2]. The emergence of cancer morbidity and
the increase in mortality in South Africa are well docu-
mented and have been attributed to different factors,
including smoking, occupational exposures, infections,
changing lifestyles, and environmental pollutants [1,3,4].
In 2003, the South African Medical Research Council
published burden of disease estimates and listed cancer
as the fourth leading cause of death and the eighth
major contributor to disability adjusted life years
(DALYs) in the country [5].
Lung cancer is most commonly attributed to smoking;
80-90% of lung cancer cases are attributed to smoking
and a smaller proportion (10-20%) is attributed to occu-
pational exposure to agents such as uranium, ionising
radiation, asbestos, silica, arsenic, beryllium, chloro-
methyl, nickel chromates, indoor emissions from burn-
ing fuels, and polycyclic aromatic hydrocarbons (PAHs)
[6-8]. The acquired immunodeficiency syndrome (HIV/
AIDS) has also recently been associated with the devel-
opment of lung cancer. A study on a cohort of HIV
positive individuals on antiretroviral therapy (ART)
showed that surviving individuals have an increased risk
of cancers previously not associated with HIV, such as
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rare anal cancer [9].
Recent changes in smoking prevalence have produced
changes in lung cancer incidence and mortality world-
wide. While there has been a substantial decline in lung
cancer rates in developed countries, such as the United
States of America (USA), Canada and many parts of
Europe [10-13], incidence rates are reportedly rising in
newly industrialised and developing countries like China
and India [14]. There are observed gender differences in
these rates, partly due to the delay in the uptake of
smoking among women, which usually lags behind that
of men by approximately 25 years [15-17]. This is
reflected in the increasing lung cancer mortality rates
seen in women, while the rates in men have leveled off
or are decreasing in many parts of the world [10-13,17].
An electronic search of the published literature
revealed that the most recent study on lung cancer mor-
tality trends in South Africa was published in 1985, cov-
ering the period 1949 to 1979 [18]. The results showed
an increasing trend in rates for lung cancers in men. In
contrast, rates were much lower and more stable in
women. No more recent data on cancer trends have
been published.
The aim of this study was to determine trends in lung
cancer mortality in the South African general population
for the period 1995 to 2006. Results are presented for
the entire population and by gender. The study also
sought to better characterise emerging trends by carry-
ing out gender-specific partitioned analyses for short-
term trends. The results will help to understand the
direction of the lung cancer epidemic in South Africa
and can assist in monitoring and projecting future rates.
This will help to inform the need for public health inter-
ventions. The results may also be useful to health practi-
tioners and policy makers in other developing countries.
Methods
Cancer deaths and population estimates
Both numerator (lung cancer deaths) and denominator
(estimates of populations at risk) data were obtained
from Statistics South Africa (StatsSA). StatsSA is the
South African government body responsible for the col-
lection, production and dissemination of official and
other statistics, the conduct of population census, and
the coordination of statistics produced by other organi-
sations in the country.
Anonymous raw mortality data were obtained from
StatsSA, from which numbers of deaths due to lung
cancer were extracted. Lung cancer deaths were defined
as deaths due to cancers of the lung and bronchus
reported on death certificates. The underlying cause of
death was coded by StatsSA. For the period 1996 to
2006, the 10
th International Classification of Diseases
(ICD 10) codes [19] were used, while ICD 9 codes [20]
were used for the year 1995. For the denominator, mid-
year total population estimates by age group and gender
were available for the entire study period. However, dis-
aggregated population estimates by age group were una-
vailable for the years 1995, and 1997 to 2000. The
population distribution, by age group, for the year 2001
(census year) was therefore applied to the population
estimates to obtain disaggregated population figures by
age group for those years.
Data analysis
Data received from StatsSA were in text and Microsoft
Excel formats and were converted to STATA 10 format
for statistical analysis (StataCorp, 2008 Texas, USA). For
descriptive purposes, the numbers of deaths due to lung
cancer were reported by gender and age group for the
most recent year, 2006. To estimate age-standardised
mortality rates for each year, the WHO world standard
population structure was used as the reference popula-
tion. Age-standardised rates were reported per 100,000
persons.
For trend analyses, scatter plots (presented as line
graphs) of age-standardised rates against year of death
were plotted, and regression models were fitted to assess
linear trends in the age-standardised mortality rates.
Models were fitted for the entire study period, and were
also partitioned from 2001 to 2006 for men and from
1999 to 2006 for women. Ninety five percent confidence
intervals (95% CI) were calculated for regression slopes.
Statistically significant slopes (p-values < 0.05) were
interpreted as average annual increases/decreases in age-
standardised mortality for the period.
Results
Deaths due to lung cancer
During the study period, there were 52,217 deaths due
to lung cancer. In the most recent year (2006), there
were 4,525 deaths. There were marked differences in the
numbers of deaths by gender and age. Most deaths
(67.4%) occurred in men. The majority of cases were 50
to 69 years of age (Table 1).
Trends in mortality due to lung cancer
For the entire South African population, the age-stan-
dardised mortality rate of 24.3 per 100,000 persons in
1995 was similar to the rate of 23.8 per 100,000 persons
in 2006. Overall, there was no significant decline in the
annual lung cancer mortality rate from 1995 to 2006
(slope = -0.15, p = 0.923). However, the rate for men
decreased from 44.2 per 100,000 persons in 1995 to
39.4 per 100,000 persons in 2006, while the rate for
women increased from 10.8 to 13.4 per 100,000 persons
(Table 2).
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mortality decreased from 2001 whereas, for women, the
rates increased from 1999. For this reason, in addition
to fitting a linear regression model for the entire study
period, models were also fitted from 2001 to 2006 for
men and from 1999 to 2006 for women.
The trends in men showed a statistically non-signifi-
cant annual decline of 0.21 deaths per 100,000 persons
for the study period. However, when the analysis was
partitioned for short-term trends, a statistically signifi-
cant average annual decline of 1.29 deaths per 100,000
persons was observed from 2001 to 2006. In women, a
significant annual increase of 0.19 per 100,000 persons
was observed for the study period. This increase was
more pronounced from 1999 to 2006 at 0.34 deaths per
100,000 persons (Table 3).
Discussion
A previous cancer trend study covering the period 1949
to 1979 demonstrated increasing lung cancer mortality
for men in South Africa [18]. Our results present a
more recent trend. The lung cancer mortality rate for
men remained stable from 1995 to 2000 but declined
significantly from 2001 to 2006, by approximately 1.3
deaths per 100,000 persons (p < 0.05) per year. Assum-
ing that this trend continues, the mortality rate of 39.4
deaths per 100,000 persons in 2006 would decrease by
one-third in approximately one decade.
While mortality due to lung cancers is on the decline
for men, the trends are in the opposite direction for
women. The rate of lung cancer mortality in South Afri-
can women was relatively low and stable until 1979
[18]. The recent trend shows that the age-standardised
mortality rate increased by 24.1% from 1995 to 2006, at
an average annual rate of 0.19 deaths per 100,000 per-
sons. In the most recent years (1999 to 2006), the rate
increased even faster at 0.34 deaths per 100,000 persons.
Assuming that this increase continues for the next dec-
ade, the mortality rate of 13.4 per 100,000 in 2006 will
reach 16.8 per 100,000 by 2016. As in many countries,
South Africa is probably yet to experience the full
impact of smoking on the incidence of tobacco-related
cancers in women.
Declining trends in lung cancer mortality rates for
men and increasing trends for women have also been
reported in Europe and America [10-13,15-17,21-23]. In
the United Kingdom, for example, age-standardised lung
cancer mortality in men decreased from 108 per
100,000 persons in 1978 to 52 per 100,000 persons in
2007 [22]. In Italy, mortality due to lung cancer and
other tobacco-related cancers was reportedly declining
in men but not in women [12]. Data presented for the
Table 1 Numbers of deaths due to lung cancer in South







20 - 29 22 (0.5)
30 - 39 94 (2.1)
40 - 49 464 (10.3)
50 - 59 1135 (25.1)
60 - 69 1420 (31.4)
70 - 79 980 (21.7)
80 and older 410 (9.1)
Table 2 Annual deaths and age-standardised mortality
rates due to lung cancer in South Africa from 1995 to
2006, by gender
Year Men Women
No. of deaths Rate* No. of deaths Rate*
1995 3019 44.2 1048 10.8
1996 3281 49.5 1293 13.9
1997 2869 40.3 1124 11.0
1998 3038 41.5 1223 11.7
1999 3184 42.8 1209 11.3
2000 2975 39.8 1195 11.1
2001 3121 46.6 1242 13.1
2002 3089 44.8 1217 12.4
2003 3038 45.1 1288 12.8
2004 3233 44.7 1413 13.5
2005 3153 41.9 1440 13.5
2006 3049 39.4 1476 13.4
*Rates per 100,000 persons are standardised to the WHO world standard
population.
Figure 1 Trends in age-standardised mortality rates (per
100,000 persons) for lung cancer in South Africa from 1995 to
2006, by gender.
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mortality increased from 5.5 per 100,000 in 1965 to 11.2
per 100,000 in 2001 [17]. In fact, the lung cancer mor-
tality rate of 13.1 per 100,000 found in our study for
2001, is similar to the 11.2 per 100,000 persons reported
for the same year in Europe [17]. Recent American stu-
dies have also reported that lung cancer mortality has
declined in men but not in women [11,13,23].
The decline in lung cancer mortality in men in South
Africa may be attributed to health promotion pro-
grammes, including public enlightenment campaigns
and the government’s comprehensive anti-smoking poli-
cies. These policies include consistent increases in the
tobacco excise tax (and, therefore, the cost of cigarettes)
and the ban on public smoking. These public health
interventions have produced a consistent decline in
smoking prevalence amongst men in South Africa [24].
Van Walbeek reported that aggregate cigarette con-
sumption dropped by 26% from 1993 to 2000 [25], 60%
of which could be explained by a reduction in the aver-
age number of cigarette smoked, and the remaining 40%
by a reduction in smoking prevalence [25]. Cheyip et al.
reported a significant decline in smoking prevalence
among men employed by a South African platinum
mining company [26].
While public health interventions, initiated more than
two decades ago, have contributed to the decline in lung
cancer mortality, the impact of the reduction in cigar-
ette smoking may become more obvious in the next
decades, given the long latency period of lung cancer.
The effect of these interventions was observed in men
and not women because of the historical difference in
smoking prevalence by gender [15,24,25].
Another factor that may affect the lung cancer mortal-
ity rate is the impact of competing causes of death due
to the HIV/AIDS epidemic. Since 1997, HIV-related
deaths have caused a shift in adult mortality towards
communicable diseases [27] and have also shortened life
expectancy from 63 years in 1990 to 51 years in 2006
[28]. This, in turn, has reduced the probability of the
development of cancers with long latency periods, such
as lung cancer, and has thus caused a reduction in lung
cancer incidence.
Also of note are reports of changing patterns of can-
cers due to anti-retroviral treatment (ART), with
increased occurrence of cancers that are not tradition-
ally linked to suppressed immunity, such as lung cancer
[9,29,30]. How ART increases the likelihood of such
cancers, and the duration of therapy required for them
to develop, is still unknown. The influence of ART on
South African lung cancer mortality trends remains to
be seen as rollout of ART began only in 2003 [31].
Conclusions
The trends in lung cancer mortality in South Africa are
similar to those in developed countries. Smoking inter-
vention policies and programmes need to be strength-
ened to further reduce lung cancer mortality in men and
to address the increasing rates of lung cancer in women.
Acknowledgements
We acknowledge the National Institute for Occupational Health, National
Health Laboratory Service, South Africa, for funding the study, and Statistics
South Africa for providing the data.
Author details
1Reproductive Health and HIV Research Unit, Faculty of Health Sciences,
University of the Witwatersrand, Johannesburg, South Africa.
2National
Institute for Occupational Health, National Health Laboratory Service,
Johannesburg, South Africa.
3School of Public Health, Faculty of Health
Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Authors’ contributions
BB substantially contributed to the conception and design of the study,
literature review, analysis and interpretation of data, drafted the manuscript
and approved the final version. OF carried out statistical analyses and
interpretation of data, contributed to drafting and revising the manuscript
and approved the final version. DK contributed to the conception and
design of the study, sought data from Statistics South Africa, contributed to
the literature review, analysis and interpretation of data, drafted the
manuscript, and approved the final version. GN contributed to the
conception and design of the study, interpretation of data, and drafting of
the manuscript, and approved the final version. All authors read and
approved the final manuscript.
Authors’ information
Braimoh Bello, MSc; M.Sc (Med) Medical Epidemiologist: Reproductive Health
and HIV Research Unit Faculty of Health Sciences, University of the
Witwatersrand, Johannesburg South Africa.
Olufolawajimi Fadahun, MD Medical Scientist: Epidemiology and Surveillance
Unit National Institute for Occupational Health, National Health Laboratory
Service South Africa.
Danuta Kielkowski, PhD Head: Epidemiology and Surveillance Unit National
Institute for Occupational Health, National Health Laboratory Service
South Africa.
Gill Nelson, MSc (Med) Research Scientist: Pathology Division National
Institute for Occupational Health, National Health Laboratory Service
South Africa.
Table 3 Regression coefficients for linear trends in age-standardised mortality rates of lung cancer in South Africa
from 1995 to 2006
Group 1995 to 2006 Partitioned analysis
Slope (95% CI) P-value Period Slope (95% CI) P-value
Entire population -0.15 (-0.34 to 0.32) 0.923
Men -0. 21 (-78 to 0.36) 0.433 2001- 2006 -1.29 (-2.0 to -0.53) 0.009
Women 0.19 (0.01 to 0.37) 0.043 1999 - 2006 0.34 (0.13 to 0.54) 0.007
Bello et al. BMC Public Health 2011, 11:209
http://www.biomedcentral.com/1471-2458/11/209
Page 4 of 5Competing interests
The authors declare that they have no competing interests.
Received: 5 November 2010 Accepted: 4 April 2011
Published: 4 April 2011
References
1. International Agency for Research on Cancer: Global Cancer Report Lyon;
2003.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin MD: Estimates of
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,
127:2893-917.
3. Van Rooyen JM, Kruger HS, Huisman HW, Wissing MP, Margetts BM,
Venter CS, Vorster HH: An epidemiological study of hypertension and its
determinants in a population in transition: the THUSA study. J Hum
Hypertens 2000, 14:779-87.
4. The National Cancer Registry of South Africa: Cancer in South Africa, 1992
Johannesburg; 1997.
5. South African Medical Research Council: Initial Burden of disease estimates
for South Africa, 2000 Pretoria; 2003.
6. International Agency for research on cancer: Monographs on evaluation of
carcinogenic risks of chemicals to humans Lyon; 1984.
7. Sematycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S: Listing
occupational carcinogens. Environ Health Perspect 2004, 112:1447-1459.
8. Driscoll T, Nelson DI, Steenland K, Leigh J, Concha-Barrientos M,
Fingerhut M: The global burden of diseases due to occupational
carcinogens. Am J Ind Med 2005, 48:419-431.
9. Long JL, Engels EA, Moore RD, Gebo KA: Incidence and outcomes of
malignancy in the HAART era in an urban cohort of HIV-infected
individuals. AIDS 2008, 22:489-496.
10. American Cancer society: Tobacco Control country profiles Georgia; 2000.
11. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al: Cancer statistics,
2006. Ca Cancer J Clin 2006, 56:106-130.
12. Malvezzi M, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Decarli A:
Cancer mortality in Italy, 2003. Tumori 2009, 95(6):655-64.
13. Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Center MM, et al: Annual
report to the nation on the state of cancer, 1975-2005, featuring trends
in lung cancer, tobacco use and tobacco control. JNCI 2008,
100(23):1672-1694.
14. Kanavos P: The rising burden of cancer in the developing world. Ann
oncol 2006, 17(Suppl 8):15-23.
15. Amos A: Women and smoking. Br Med Bull 1996 52:74-89.
16. Mackay J, Amos A: Women and tobacco. Respirology 2003, 8(2):123-130.
17. Bosetti C, Levi F, Lucchini F, Negri E, La Vecchia C: Lung cancer mortality
in European women: recent trends and perspectives. Ann Oncol 2005,
16:1597-1604.
18. Bradshaw E, Harington JS: The changing pattern of cancer mortality in
South Africa, 1949-1979. S Afr Med J 1985, 68:455-65.
19. World Health Organisation: World Health Organization International Statistical
Classification of Disease and Related Health Problems, 10th revision Geneva;
1992.
20. World Health Organisation: World Health Organization International Statistical
Classification of Disease: 9th Revision Geneva; 1977.
21. Brennan P, Bray I: Recent trends and future directions for lung cancer
mortality in Europe. Br J Cancer 2002, 87(1):43-48.
22. UK lung cancer mortality statistics. [http://www.cancerresearchuk.org].
23. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun M: Cancer Statistics
2008. CA Cancer J Clin 2008, 58:71-96.
24. Peltzer K: Tobacco use trends among adolescents and adults in South
Africa. Journal of Psychology in Africa 18(2):339-346.
25. Van Walbeek C: Recent trends in smoking prevalence in South Africa -
some evidence from AMPS data. S Afr Med J 2002, 92:468-472.
26. Cheyip M, Nelson G, Ross MH, Murray J: South African platinum mine
employees reduce smoking in 5 years. Tobacco Control 2007, 16:197-201.
27. Naidoo S: How successful is South Africa in decreasing communicable
diseases? South Afr J Epidemiol Infect 2008, 23:10-12.
28. Dorrington RE, Johnson LF, Bradshaw D, Daniel T: The demographic
impact of HIV/AIDS in South Africa. National and Provincial indicators for
2006. South African Medical Research Council and Actuarial Society of
South Africa; 2006.
29. Clifford GM, Polesel J, Rickenbach , Dal Maso L, Keiser O, Kofler A, et al:
Cancer risk in the Swiss HIV cohort study: associations with
immunodeficiency, smoking, and highly active antiretroviral therapy. J
Natl Cancer Inst 2005, 97(6):425-32.
30. Nutankalva L, Wutoh AK, McNeil J, Frederick WR, Reddy RB, Daftary M,
Gentles A, Addae-Afoakwa K: Malignancies in HIV: pre- and post-
highly active antiretroviral therapy. JN a t lM e dA s s o c2008,
100(7):817-20.
31. Nattrass N: South Africa’s “rollout of highly active antiretroviral therapy: a
critical assessment. J Acquir Immune Defic Syndr 2006, 43(5):18-23.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/209/prepub
doi:10.1186/1471-2458-11-209
Cite this article as: Bello et al.: Trends in lung cancer mortality in South
Africa: 1995-2006. BMC Public Health 2011 11:209.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bello et al. BMC Public Health 2011, 11:209
http://www.biomedcentral.com/1471-2458/11/209
Page 5 of 5